Achilles Therapeutics Excels in Q2 with Promising Trials
PremiumCompany AnnouncementsAchilles Therapeutics Excels in Q2 with Promising Trials
3M ago
Achilles Therapeutics reports Q2 EPS (41c) vs (42c) last year
Premium
The Fly
Achilles Therapeutics reports Q2 EPS (41c) vs (42c) last year
3M ago
Leadership Shift at Achilles Therapeutics
Premium
Company Announcements
Leadership Shift at Achilles Therapeutics
3M ago
Achilles Therapeutics: Promising Q1 2024 Results
PremiumCompany AnnouncementsAchilles Therapeutics: Promising Q1 2024 Results
6M ago
Achilles Therapeutics reports Q1 EPS (30c), consensus (46c)
Premium
The Fly
Achilles Therapeutics reports Q1 EPS (30c), consensus (46c)
6M ago
Piper downgardes Achilles Therapeutics, says ‘step-function’ change needed
Premium
The Fly
Piper downgardes Achilles Therapeutics, says ‘step-function’ change needed
7M ago
Achilles Therapeutics Plc (ACHL) Q4 Earnings Cheat Sheet
PremiumPre-EarningsAchilles Therapeutics Plc (ACHL) Q4 Earnings Cheat Sheet
9M ago
Achilles announces publication on neoantigen immunogenicity prediction
Premium
The Fly
Achilles announces publication on neoantigen immunogenicity prediction
11M ago
Achilles Therapeutics just downgraded at BofA, here’s why
Premium
The Fly
Achilles Therapeutics just downgraded at BofA, here’s why
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100